S02E10 | Rubinstein Taybi Syndrome: A Lifetime Clinical and Molecular Roadmap

Rubinstein-Taybi Syndrome: A Lifetime Clinical and Molecular Roadmap ABSTRACT This episode explores Rubinstein-Taybi syndrome (RSTS) as a lifelong multisystem disorder rooted in a microscopic failure of epigenetic regulation. Beginning with the remarkable clinical observations of Jack Rubinstein and Houshang Taybi in the early 1960s, we trace how modern medicine now understands RSTS as a disorder of chromatin remodeling, most commonly caused by pathogenic variants in CREBBP and less frequently EP300. We examine how disruption of histone acetyltransferase activity prevents critical developmental genes from being properly “opened” and read during embryogenesis, creating a cascade of anatomical, neurological, metabolic, and systemic consequences. The discussion covers the syndrome’s distinct craniofacial and skeletal hallmarks, severe motor and cognitive challenges, feeding difficulties, altered growth trajectories, obesity risk, congenital organ anomalies, dermatologic complications like keloids, and the evolving paradox of survival: thanks to pediatric advances, most patients now reach adulthood, transforming RSTS from a pediatric mortality syndrome into a complex lifespan condition. This episode is a comprehensive roadmap through the molecular origins, clinical expression, and lifelong care burdens of a profoundly intricate genetic disorder. CLINICS & SERVICES Book an appointment: https://appointments.conciercare.net/... Read more in the CONCIERCARE newsroom feature: https://health.conciercare.net/news/p... OBJECTIVES 1. Who were the primary physicians credited with defining Rubinstein-Taybi syndrome, and when was it formally established? 2. Describe the genetic cause of RSTS and the role of the genes involved. 3. What are the primary differences between RSTS Type 1 (RTS1) and RSTS Type 2 (RTS2)? 4. Explain the significance of the "talon cusp" in the diagnosis of RSTS. 5. Describe the characteristic orthopedic malformations of the distal limbs in RSTS patients. 6. How does the growth trajectory of an individual with RSTS typically shift from infancy to adolescence? 7. What is Menke-Hennekam syndrome, and why is it a significant differential diagnosis for RSTS? 8. Describe the behavioral evolution that often occurs as a child with RSTS matures into adulthood. 9. What specific respiratory complication has recently been causally linked to RSTS, and what drives its development? 10. Why is the transition from pediatric to adult medical care considered a "systemic failure" for many RSTS patients? Join the conversation—Were you surprised by how a microscopic failure in gene regulation can reshape growth, cognition, and organ development across an entire lifetime? Share your thoughts in the comments. ABOUT US CONCIERCARE is a neuroscience- and genetics-informed health system committed to integrating molecular medicine, developmental care, and lifelong multidisciplinary support for rare disorders. Learn more at: https://health.conciercare.net COPYRIGHT & DISCLAIMER https://health.conciercare.net/news/p... - Funding & Ethical Disclosures #RubinsteinTaybiSyndrome, #RareDisease, #Genetics, #Epigenetics, #ChromatinRemodeling, #CREBBP, #EP300, #DevelopmentalDisorders, #Pediatrics, #Neurodevelopment, #RareSyndromes, #PrecisionMedicine, #LifelongCare